Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy and Transplantation: The Role of Immunosuppression in Malignancy and a Review of Antineoplastic Agents in Solid Organ Transplant Recipients
Jill C. Krisl, Vincent Doan
American Journal of Transplantation (2017) Vol. 17, Iss. 8, pp. 1974-1991
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Role of the oral microbiota in cancer evolution and progression
Jiwei Sun, Qingming Tang, Shaoling Yu, et al.
Cancer Medicine (2020) Vol. 9, Iss. 17, pp. 6306-6321
Open Access | Times Cited: 118
Clonal hematopoiesis: Mutation-specific adaptation to environmental change
Marcus A. Florez, Brandon T. Tran, Trisha K. Wathan, et al.
Cell stem cell (2022) Vol. 29, Iss. 6, pp. 882-904
Open Access | Times Cited: 69
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023
Alexander J. Stratigos, Claus Garbe, Clio Dessinioti, et al.
European Journal of Cancer (2023) Vol. 193, pp. 113251-113251
Open Access | Times Cited: 37
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023
Alexander J. Stratigos, Claus Garbe, Clio Dessinioti, et al.
European Journal of Cancer (2023) Vol. 193, pp. 113252-113252
Open Access | Times Cited: 36
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
Orhan Efe, Rodrigo Benedetti Gassen, Leela Morená, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 5
Open Access | Times Cited: 10
Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma
Anna Maria Wirsing, Ida Korsnes Ervik, Marit Seppola, et al.
Modern Pathology (2018) Vol. 31, Iss. 6, pp. 910-922
Open Access | Times Cited: 83
Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management
John J. Griffith, Kamal Adel Amin, Nikhil Waingankar, et al.
American Journal of Transplantation (2017) Vol. 17, Iss. 11, pp. 2775-2781
Open Access | Times Cited: 61
Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy
Tianqi Wang, Yusuke Suita, Saradha Miriyala, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 520-520
Open Access | Times Cited: 38
Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?
Jan Lerut, Samuele Iesari, Maxime Foguenne, et al.
Translational Gastroenterology and Hepatology (2017) Vol. 2, Iss. 10, pp. 80-80
Open Access | Times Cited: 44
Cancer mortality in kidney transplant recipients: An Australian and New Zealand population‐based cohort study, 1980–2013
Brenda Rosales, Nicole De La Mata, Claire M. Vajdic, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 10, pp. 2703-2711
Open Access | Times Cited: 40
Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics
Xueqing Zhang, Yamei Huang, Heliang Song, et al.
Journal of Controlled Release (2020) Vol. 328, pp. 454-469
Closed Access | Times Cited: 39
Immune-related pneumonitis associated with immune checkpoint inhibitors in lung cancer: a network meta-analysis
Xinru Chen, Zhonghan Zhang, Xue Hou, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001170-e001170
Open Access | Times Cited: 37
Nitidine chloride exerts anti-inflammatory action by targeting Topoisomerase I and enhancing IL-10 production
Niao Yang, Rongcai Yue, Jinzhu Ma, et al.
Pharmacological Research (2019) Vol. 148, pp. 104368-104368
Closed Access | Times Cited: 36
Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
Hung-Chih Lai, Ji‐Fan Lin, Thomas I.S. Hwang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2194-2194
Open Access | Times Cited: 35
Evolving Role of Systemic Therapies in Non-melanoma Skin Cancer
Claudio Conforti, Paola Corneli, Catherine Α. Harwood, et al.
Clinical Oncology (2019) Vol. 31, Iss. 11, pp. 759-768
Closed Access | Times Cited: 34
Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis
Api Chewcharat, Charat Thongprayoon, Wisit Cheungpasitporn, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 4, pp. 530-530
Open Access | Times Cited: 33
Comparing surgical outcomes between robot-assisted laparoscopic and open partial nephrectomy for allograft kidney tumors: a retrospective, single-center study
Taro Banno, Yuki Kobari, Hironori Fukuda, et al.
BMC Surgery (2025) Vol. 25, Iss. 1
Open Access
Forty years of kidney transplantation: Insights into malignancies at a single center in Latin America
Pilar Musalem, Carolina Sáez-Vera
Transplant Immunology (2025), pp. 102216-102216
Closed Access
Oncological Complications of Liver Transplantation: A Narrative Review on De Novo and Donor-Transmitted Cancers
Tancredi Vincenzo Li Cavoli, Armando Curto, Erica Nicola Lynch, et al.
Transplantology (2025) Vol. 6, Iss. 2, pp. 15-15
Open Access
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
Dag Olav Dahle, Morten Skauby, Carl W. Langberg, et al.
Transplantation (2021) Vol. 106, Iss. 1, pp. e52-e63
Open Access | Times Cited: 21
Posttransplant Malignancy
Ana Rossi, Christina L. Klein
Surgical Clinics of North America (2018) Vol. 99, Iss. 1, pp. 49-64
Closed Access | Times Cited: 25
Survival among solid organ transplant recipients diagnosed with cancer compared to nontransplanted cancer patients—A nationwide study
Henrik Benoni, Sandra Eloranta, Anders Ekbom, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 3, pp. 682-691
Open Access | Times Cited: 24
Systematic review of ablative therapy for the treatment of renal allograft neoplasms
Evaldo Favi, Nicholas Raison, Federico Ambrogi, et al.
World Journal of Clinical Cases (2019) Vol. 7, Iss. 17, pp. 2487-2504
Open Access | Times Cited: 24
Malignancies in adult kidney transplant candidates and recipients: current status
Krystyna Serkies, Alicja Dębska‐Ślizień, Anna Kowalczyk, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 7, pp. 1591-1602
Closed Access | Times Cited: 14
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning
Jonathan Pol, Matthew J. Atherton, Kyle B. Stephenson, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000981-e000981
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top